A blueprint for better cancer immunotherapies
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
MIT graduate student earns top honors in Graduate and People’s Choice categories for her work on nutrient-stabilizing materials.
The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.
The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors.
Professors Matthew Vander Heiden and Fan Wang, along with five MIT alumni, are honored for their outstanding professional achievement and commitment to service.
Labs that can’t afford expensive super-resolution microscopes could use a new expansion technique to image nanoscale structures inside cells.
Study reveals the drug, 5-fluorouracil, acts differently in different types of cancer — a finding that could help researchers design better drug combinations.
MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.
Fasting helps intestinal stem cells regenerate and heal injuries but also leads to a higher risk of cancer in mice, MIT researchers report.
Professor who uses a cross-disciplinary approach to understand human diseases on a molecular and cellular level succeeds Elazer Edelman.
Staff members receive recognition for their exceptional support of the MIT community.
A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.
By designing new tools that can analyze huge libraries of immune cells and their targets, Michael Birnbaum hopes to generate better T cell therapies for cancer and other diseases.
Known for her rigorous approach to science and her influential research, Pardue paved the way for women in science at MIT and beyond.
MIT scientists honored in each of the three Kavli Prize categories: neuroscience, nanoscience, and astrophysics, respectively.